We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-8.78%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
AUM
$105M
AUM Growth
-$22.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 76.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVN
1
DELISTED
Trevena, Inc.
TRVN
$22.1M 21.09%
4,271
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
$19.9M 19.01%
404
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$15.2M 14.56%
246,076
OCUL icon
4
Ocular Therapeutix
OCUL
$1.83B
$11.9M 11.35%
1,230,009
PULM icon
5
Pulmatrix
PULM
$6.1M
$10.6M 10.1%
18,040
DARE icon
6
Dare Bioscience
DARE
$17.4M
$8.91M 8.51%
27,396
ATYR
7
aTyr Pharma
ATYR
$47.4M
$7.2M 6.88%
130,571
FATE icon
8
Fate Therapeutics
FATE
$275M
$4.45M 4.25%
2,473,186
BIND
9
DELISTED
BIND THERAPEUTICS INC
BIND
$4.44M 4.24%
2,018,253

Similar funds

Polaris Venture Management Co V's Q1 2016 Portfolio in Review

As of Q1 2016, Polaris Venture Management Co V held 9 positions worth $105M, down 18% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 0%. Polaris Venture Management Co V opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 79% a quarter earlier.

  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $105M portfolio in Q1 2016.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q1 2016.
  • Polaris Venture Management Co V's portfolio value fell 18% quarter-over-quarter to $105M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2016, filed 13 May 2016.